期刊文献+

固相萃取-气相色谱-质谱法检验人血浆中的右美托咪定 被引量:4

Determination of dexmedetomidine in human plasma by solid phase extraction with gas chromatography-mass spectrometry
原文传递
导出
摘要 目的采用固相萃取结合气相色谱-质谱法(SPE-GC/MS)检验人血浆中盐酸右美托咪定。方法采用SPE提取血浆,用GC-MS/MS方法测定。结果盐酸右美托咪定在0.2μg/m L^5.0μg/m L范围内与峰面积呈现良好的线性关系(r2=0.999 1),检出限为20.0ng/m L,回收率为86.1%~91.5%,日内日间精密度均小于7.86%。结论本方法操作简单,结果准确,可以作为测定人血浆中右美托咪定的方法。 Objective To develop the analytical method of dexmedetomidine in human plasma by solid phase extraction with gas chromatography-mass spectrometry(SPE-GC/MS). Methods The human plasma were extracted with a solid phase extraction(SPE) and determined by GC/MS. Results The lowest detectable limit was 0.05μg/m L, the standard curve was linear over the range of 0.2μg/m L^5μg/m L. The absolute recovery was 86.1%~91.5%. The intraand interday precision was within 7.86% at three concentrations. Conclusion Since the procedure proved to be simple, quick and sensitive, it could be used for the determination of dexmedetomidine in human plasma.
出处 《中国法医学杂志》 CSCD 2017年第5期497-499,共3页 Chinese Journal of Forensic Medicine
基金 中央级公益性科研院所基本科研业务费专项基金计划项目"体液中丙泊酚 甲苯噻嗪 右美托咪定三种快速麻醉药的检验方法研究预言"(No.2013JBYY001)
关键词 法医毒物分析 右美托咪定 血浆 固相萃取 气相色谱-质谱 forensic toxicological analysos dexmedetomidine plasm solid phase extraction gaschromatography-mass spectrometry
  • 相关文献

参考文献5

二级参考文献116

  • 1钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:580
  • 2PARIS A, TONNER P H. Dexmedetomidine in anaesthesia [ J ]. Curr Opin Anaesthesiol,2005, 18 ( 3 ) :412-418.
  • 3GUO T Z, JIANG J Y, BUTFERMANN A E, et al. Dexmedetomidine injection into the locus eeruleus produces antinociception [ J ]. Anesthesiology, 1996, 84 ( 7 ) : 873 - 881.
  • 4NELSON L E, LU J, GUO T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects [ J ]. Anesthesiology, 2003,98 ( 3 ) :428-436.
  • 5NACIF-COELHO C, CORREA-SALES C, CHANG L L, et al. Perturbation of ion channel conductance alters the hypnotic response to the alpha 2-adrenergic agonist dexmedetomidine in the locus coeruleus of the rat [ J ]. Anesthesiology, 1994, 81 (10) : 1527-1534.
  • 6EISENACH J C, SHAFER S L, BUCKLIN B A, et al. Pharmacokinetics and pharmacodynamics of intraspinal dexmedetomidine in sheep [ J ]. Anesthesiology, 1994, 80 (9) :1349-1359.
  • 7VENN R M, BRADSHAW C J, SPENCER R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit [ J ]. Anaesthesia, 1999,54 ( 8 ) : 1136-1142.
  • 8CORTINEZ L I, HSU Y W, SUM-PING S T, et al. Dexmedetomidine pharmacodynamics, part II : crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers [ J ]. Anesthesiology, 2004,101 (7) :1077-1083.
  • 9HOFFMAN W E, KOCHS E, WERNER C, et al. Dexmedetomidine improves neurologic outcome from incomplete isehemia in the rat: reversal by the alpha 2-adrenergic antagonist atipamezole [ J ]. Anesthesiology, 1991,75 ( 2 ) : 328 -332.
  • 10ZORNOW M H, FLEISCHER J E, SCHELLER M S, et al. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anestbetized dog [J]. Artesth Analg,1990,70(5) :624-630.

共引文献237

同被引文献77

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部